Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

Yasaman Anbari , Floortje E. Veerman , Grace Keane , Arthur J.A.T. Braat , Maarten L.J. Smits , Rutger C.G. Bruijnen , Wenle Tan , Ye Li , Feng Duan , Marnix G.E.H. Lam
{"title":"Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer","authors":"Yasaman Anbari ,&nbsp;Floortje E. Veerman ,&nbsp;Grace Keane ,&nbsp;Arthur J.A.T. Braat ,&nbsp;Maarten L.J. Smits ,&nbsp;Rutger C.G. Bruijnen ,&nbsp;Wenle Tan ,&nbsp;Ye Li ,&nbsp;Feng Duan ,&nbsp;Marnix G.E.H. Lam","doi":"10.1016/j.jimed.2023.09.001","DOIUrl":null,"url":null,"abstract":"<div><p>Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (<sup>90</sup>Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with <sup>90</sup>Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of <sup>90</sup>Y microspheres in the treatment of liver cancer.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096360223000479/pdfft?md5=5035fae5d67492f85a90cced74213303&pid=1-s2.0-S2096360223000479-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Interventional Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2096360223000479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
钇-90微球放射栓塞治疗原发性和转移性肝癌的现状
肝脏恶性肿瘤,包括原发性肝癌和转移性肝癌,由于恶性程度高、系统治疗策略有限,已成为全球最常见的癌症相关死亡原因之一。钇-90(90Y)负载微球放射栓塞是一种相对新颖的技术,在肝脏恶性肿瘤的局部治疗方面取得了重大进展。本文从技术和临床两方面讨论了对有 90Y 微球治疗适应症的患者进行放射性栓塞治疗的大量工作中,从患者选择到随访的不同步骤。本文介绍了 90Y 微球在肝癌治疗中的应用和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Interventional Medicine
Journal of Interventional Medicine Medicine-General Medicine
CiteScore
1.30
自引率
0.00%
发文量
32
审稿时长
68 days
期刊最新文献
Baseline parameters of spectral CT could predict tumor response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy Diagnostic radiology: The essential for effective and safe practice of interventional radiology Percutaneous radiofrequency and microwave ablation for renal pelvic urothelial carcinoma with refractory hematuria: A case report Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1